Daily Mail

I see so many male patients whose sleep is ruined by constantly needing to pee at night. What many don't realise is that they don't have a bladder problem... but a cur…

Ken, like many men, had been nagged into coming to see me by his wife. She was exhausted. Every time he got up in the night ...

Endometriosis can affect the bowel, bladder and nerves: Why a ‘normal’ scan may not rule it out

For millions of women, severe period pain is still treated as something they are simply expected to endure. But when pain ...

"I can walk, so I'm fine" is not enough—The "invisible symptoms" of Parkinson's disease from the perspective of a caregiver

When it comes to Parkinson's disease, we inevitably focus on "movement," such as tremors, freezing of gait, and rigidity.But ...
India West

California Surgeon Inderbir Gill Leads World’s First Human Bladder Transplant

LOS ANGELES, CA– In a groundbreaking achievement set to reshape the future of transplant medicine, Dr. Inderbir S. Gill has led the world’s first successful bladder transplant in a human being. The ...
Pharmabiz

US FDA accepts and grants priority review status to AstraZeneca’s sBLA for Imfinzi plus neoadjuvant enfortumab vedotin to treat patients with muscle-invasive bladder cancer

US FDA accepts and grants priority review status to AstraZeneca’s sBLA for Imfinzi plus neoadjuvant enfortumab vedotin to treat patients with muscle-invasive bladder cancer: Cam ...
RTTNews

AstraZeneca's IMFINZI-Enfortumab Regimen Wins FDA Priority Review In Bladder Cancer

AstraZeneca plc ( AZN) announced that the U.S. FDA has accepted and granted Priority Review to its supplemental Biologics License Application for IMFINZI in combination with enfortumab vedotin (EV) ...
MarketScreener

AstraZeneca?s IMFINZI Plus Neoadjuvant Enfortumab Vedotin Receives Priority Review In The US For Patients With Muscle-Invasive Bladder Cancer

AstraZeneca?s supplemental Biologics License Application (sBLA) for IMFINZI® (durvalumab) in combination with enfortumab vedotin (EV) was accepted and granted Priority Review in the US for the ...
pharmaphorum

FDA starts speedy review of Imfinzi in bladder cancer

The US regulatory agency has just started a priority review of Imfinzi (durvalumab), in combination with Pfizer and ...
EuropaWire

AstraZeneca’s Imfinzi Plus Enfortumab Vedotin Granted US Priority Review for Cisplatin-Ineligible Muscle-Invasive Bladder Cancer

AstraZeneca’s supplemental Biologics License Application for Imfinzi in combination with enfortumab vedotin has been accepted and granted Priority Review by the US FDA for patients with ...
oncodaily

FDA Grants Priority Review to Perioperative Durvalumab Plus Neoadjuvant Enfortumab Vedotin for Muscle-Invasive Bladder Cancer

FDA Grants Priority Review to Perioperative Durvalumab Plus Neoadjuvant Enfortumab Vedotin for Muscle-Invasive Bladder Cancer ...

AstraZeneca bladder cancer combination wins FDA priority review

AstraZeneca PLC has secured a priority review in the US for its Imfinzi immunotherapy combined with enfortumab vedotin in ...
Cancer Therapy Advisor

ASTRO Issues Clinical Practice Guideline for Use of RT in Bladder Cancer

The new clinical guideline was developed by a multidisciplinary task force of radiation, medical, and urologic oncologists, a medical physicist, and a patient representative who reviewed published ...